Second Sight Reports Third Quarter 2017 Financial Results
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today reported financial results for the three- and nine-month periods ended September 30, 2017. Recent Company Highlights: Generated net sales of $1.6 million in the third quarter of 2017, compared to $1.2 million in the th